Condition
Anticoagulant Adverse Reaction clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Anticoagulant Adverse Reaction clinical trials that are recruiting, at sites in 7 countries (most in Belgium (1), China (1), France (1)). By phase: Phase 4 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 7Countries
Newest Anticoagulant Adverse Reaction clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Discontinuing anticoagulants after heart surgery for atrial fibrillation | Phase 4 | Copenhagen, Capital Region and 5 other locations | Recruiting | May 7, 2024 |
| Evaluating Rivaroxaban for Atrial Fibrillation Patients | Phase 4 | Seoul | Recruiting | Jan 2, 2024 |
| Comparing low-dose and standard-dose rivaroxaban for elderly patients with atrial fibrillation | Phase 4 | Beijing, Beijing Municipality | Recruiting | Oct 31, 2023 |
| Using CytoSorb device for patients with acute on chronic liver failure | — | Edegem, Antwerp | Recruiting | Oct 12, 2023 |
| Developing cardiac surgery services to treat rheumatic heart disease in Ethiopia | — | Addis Ababa and 3 other locations | Recruiting | Sep 21, 2020 |
| Managing anticoagulation in patients with benign prostatic hyperplasia undergoing laser surgery | — | Toulouse | Recruiting | Sep 29, 2017 |
All recruiting trials (6)
-
Discontinuing anticoagulants after heart surgery for atrial fibrillation
This study is testing if people with atrial fibrillation can safely stop taking blood thinners after having surgery to close a part of their heart, to see if it helps avoid bleeding problems.
-
Evaluating Rivaroxaban for Atrial Fibrillation Patients
This study is testing two different doses of Rivaroxaban to see which one works better for preventing strokes in people with non-valvular atrial fibrillation.
-
Comparing low-dose and standard-dose rivaroxaban for elderly patients with atrial fibrillation
This study is testing whether a lower dose of rivaroxaban works just as well as the standard dose for older adults with atrial fibrillation to prevent strokes and heart problems while reducing side effects.
-
Using CytoSorb device for patients with acute on chronic liver failure
This study tests if using the CytoSorb device can help lower bilirubin and ammonia levels and improve muscle strength in patients with severe liver failure.
-
Developing cardiac surgery services to treat rheumatic heart disease in Ethiopia
This study is trying to set up a heart surgery service in Ethiopia to help people with rheumatic heart disease and see how well the surgery works compared to those who can’t get it.
-
Managing anticoagulation in patients with benign prostatic hyperplasia undergoing laser surgery
This study is testing whether keeping patients on blood thinners or stopping them before laser surgery for prostate enlargement is safer and leads to fewer complications.
Related topics
Quick answers
How many Anticoagulant Adverse Reaction clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Belgium (1 trial), China (1 trial), France (1 trial), South Korea (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.